-
Scotland vaccination drive linked to big drop in hospital admissions
Pfizer jab cuts risk of admission by up to 85% four weeks after first dose, while AstraZeneca jab cuts risk by 94%, study finds Scotland
The Covid-19 vaccination programme has been linked to a substantial reduction in hospital admissions in Scotland, experts have said.
Researchers examined coronavirus hospital admissions among people who have had their first jab and compared them with those who had not yet received a dose of the vaccine.
Scientists from the University of Edinburgh, the University of Strathclyde and Public Health Scotland examined data on people who had received either the Pfizer/BioNTech jab or the vaccination developed by experts at the University of Oxford with AstraZeneca.
By the fourth week after receiving the initial dose, the Pfizer and Oxford/AstraZeneca vaccines were shown to reduce the risk of hospital admission from Covid-19 by up to 85% and 94%, respectively, they found.
The lead researcher of the Scotland vaccine study, Prof Aziz Sheikh, the director of the University of Edinburgh’s Usher Institute, said: “These results are very encouraging and have given us great reasons to be optimistic for the future.
“We now have national evidence – across an entire country – that vaccination provides protection against Covid-19 hospitalisations.”
Dr Jim McMenamin, national Covid-19 incident director at Public Health Scotland, said: “These results are important as we move from expectation to firm evidence of benefit from vaccines.
“Across the Scottish population the results show a substantial effect on reducing the risk of admission to hospital from a single dose of vaccine. For anyone offered the vaccine I encourage them to get vaccinated.”
Chris Robertson, the professor of public health epidemiology at the University of Strathclyde, said: “These early national results give a reason to be more optimistic about the control of the epidemic.”
source: MacLeod
You May Also Like
Popular Posts
Caricature
opinion
Report
ads
Newsletter
Subscribe to our mailing list to get the new updates!